FzioMed reaches 400k-unit milestone of Oxiplex gel manufacture: 5 takeaways

FzioMed has shipped 400,000 units of Oxiplex gel.

Advertisement

Here are five takeaways:

 

1. Oxiplex is an absorbable gel that is applied to spinal nerve roots during lumbar laminectomy, laminotomy and discectomy procedures for the treatment of herniated discs.

 

2. Oxiplex’s efficacy has been shown in numerous clinical trials.

 

3. Oxiplex is approved outside the United States in 70 countries.

 

4. It is distributed under the brand names Oxiplex, Oxiplex/SP and MediShield.

 

5. FzioMed is a privately held medical device company that develops, manufactures and markets absorbable surgical biomaterials.

 

More articles on devices:
15 things to know about Zimmer Biomet
DePuy Synthes invests $60M in expanded manufacturing plant in Ireland: 4 things to know
3D Systems named to top 50 ‘smartest companies’ list: 5 observations

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.